# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000310158-18-000005
Filing Date
2018-02-27
Accepted
2018-02-27 16:33:07
Documents
143
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 2017 FORM 10-K | mrk1231201710k.htm | 10-K | 4624121
2 | EXHIBIT 10.12: 2018 NQSO GRANT TERMS UNDER MERCK CO INC 2010 ISP | ex1012_2018nqsogranttermsu.htm | EX-10.12 | 44960
3 | EXHIBIT 10.17: 2018 RSU GRANT TERMS UNDER MERCK CO INC 2010 ISP | ex1017_2018restrictedstock.htm | EX-10.17 | 45495
4 | EXHIBIT 10.24: PLAN FOR DEFERRED PAYMENT OF DIRS COMP AMENDED & RESTATED 010118 | ex1024planfordeferredpayme.htm | EX-10.24 | 68274
5 | EXHIBIT 12: COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES | ex12computationofratiosofe.htm | EX-12 | 61547
6 | EXHIBIT 21: SUBSIDIARY LIST | ex21subsidiarylistasof1231.htm | EX-21 | 252308
7 | EXHIBIT 23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23consentofindependentre.htm | EX-23 | 2707
8 | EXHIBIT 24.1: POWER OF ATTORNEY | ex241powerofattorneymrk123.htm | EX-24.1 | 20817
9 | EXHIBIT 24.2: CERTIFICATION OF BOARD RESOLUTION | ex242certificationofboardr.htm | EX-24.2 | 9769
10 | EXHIBIT 31.1: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311rule13a-14a15dx14acer.htm | EX-31.1 | 8502
11 | EXHIBIT 31.2: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312rule13a-14a15dx14acer.htm | EX-31.2 | 8632
12 | EXHIBIT 32.1: SECTION 1350 CERTIFICATION OF CEO | ex321section1350certificat.htm | EX-32.1 | 4783
13 | EXHIBIT 32.2: SECTION 1350 CERTIFICATION OF CFO | ex322section1350certificat.htm | EX-32.2 | 5095
20 |  | electronicsignaturedavisa04.jpg | GRAPHIC | 31485
21 |  | g438975g32h99a01a04.jpg | GRAPHIC | 7017
22 |  | mrk1231201_chart-58501a04.jpg | GRAPHIC | 44675
23 |  | pwcsignature2013a04.jpg | GRAPHIC | 38342
| Complete submission text file | 0000310158-18-000005.txt |  | 27004111

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL INSTANCE DOCUMENT | mrk-20171231.xml | EX-101.INS | 8067542
15 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20171231.xsd | EX-101.SCH | 115010
16 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20171231_cal.xml | EX-101.CAL | 195428
17 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20171231_def.xml | EX-101.DEF | 766926
18 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20171231_lab.xml | EX-101.LAB | 1575158
19 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20171231_pre.xml | EX-101.PRE | 1062407

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 18645557
SIC: 2834 Pharmaceutical Preparations